Open menuDiscover

---

financetop newsweatherentertainmentsportslifestylehealthdiningtravelautos

Takeda’s TAK-330 Nears Key Milestones in High-Stakes Emergency Surgery Trial

Takeda Pharmaceutical Company ($TAK) announced an update on their ongoing clinical study. Takeda is running a Phase 3 trial to test TAK-330, a drug designed to quic...TipRanks

Zanubrutinib Update: What BeiGene’s BTK Intolerance Study Means for Oncology Investors

BeOne Medicines ($ONC) announced an update on their ongoing clinical study. Study Overview: This Phase 2 study, officially titled “A Phase 2, Multicenter, Single-ar...TipRanks

When Does Jerome Powell's Term End?

How many more Fed meetings will Powell chair? This week's policy meeting is Jerome Powell's third-to-last as Federal Reserve chair. His term ends on May 15. How long has Powell been at the Fed? Powell has been on the Fed board since 2012 and has served as its chair since February 2018Wall Street Journal

Takeda Advances Zasocitinib Phase 3 Trial in Psoriatic Arthritis: What Investors Should Know

Takeda Pharmaceutical Company ($TAK) announced an update on their ongoing clinical study. Takeda’s latest phase 3 study, officially titled “A Multi-Center, Randomiz...TipRanks

Nvidia Stock: The Road To New All-Time Highs In 2026

Historically, NVDA has undergone several significant rallies.Forbes